126 related articles for article (PubMed ID: 33421522)
1. Obesity-induced upregulation of microRNA-183-5p promotes hepatic triglyceride accumulation by targeting the B-cell translocation gene 1.
Zhou X; Yuan Y; Teng F; Li K; Luo S; Zhang P; Liu D; Zhang H; Zhang J
Life Sci; 2021 Mar; 268():119011. PubMed ID: 33421522
[TBL] [Abstract][Full Text] [Related]
2. Obesity-induced upregulation of miR-361-5p promotes hepatosteatosis through targeting Sirt1.
Zhang Z; Liu X; Xu H; Feng X; Lin Y; Huang Y; Peng Y; Gu M
Metabolism; 2018 Nov; 88():31-39. PubMed ID: 30309516
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of microRNA-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia.
Ng R; Wu H; Xiao H; Chen X; Willenbring H; Steer CJ; Song G
Hepatology; 2014 Aug; 60(2):554-64. PubMed ID: 24677249
[TBL] [Abstract][Full Text] [Related]
4. miR-212-5p suppresses lipid accumulation by targeting FAS and SCD1.
Guo Y; Yu J; Wang C; Li K; Liu B; Du Y; Xiao F; Chen S; Guo F
J Mol Endocrinol; 2017 Oct; 59(3):205-217. PubMed ID: 28667176
[TBL] [Abstract][Full Text] [Related]
5. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.
Liu X; Chen S; Zhang L
Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E34-E42. PubMed ID: 32228319
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1.
Wu GY; Rui C; Chen JQ; Sho E; Zhan SS; Yuan XW; Ding YT
Cell Physiol Biochem; 2017; 44(4):1651-1664. PubMed ID: 29216638
[TBL] [Abstract][Full Text] [Related]
7. MiR-192-5p Ameliorates Hepatic Lipid Metabolism in Non-Alcoholic Fatty Liver Disease by Targeting
Ma L; Song H; Zhang CY; Hou D
Biomolecules; 2023 Dec; 14(1):. PubMed ID: 38254634
[TBL] [Abstract][Full Text] [Related]
8. miR-1224-5p Enhances Hepatic Lipogenesis by Targeting Adenosine Monophosphate-Activated Protein Kinase α1 in Male Mice.
Chen T; Yan D; Cheng X; Ji X; Bian J; Yin W
Endocrinology; 2018 May; 159(5):2008-2021. PubMed ID: 29474539
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA AC012668 suppresses non-alcoholic fatty liver disease by competing for microRNA miR-380-5p with lipoprotein-related protein LRP2.
Chen X; Ma H; Gao Y; Jin Y; Ning W; Hou Y; Su J
Bioengineered; 2021 Dec; 12(1):6738-6747. PubMed ID: 34511037
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of miR-181a impairs lipid metabolism by targeting PPARα expression in nonalcoholic fatty liver disease.
Huang R; Duan X; Liu X; Cao H; Wang Y; Fan J; Wang B
Biochem Biophys Res Commun; 2019 Jan; 508(4):1252-1258. PubMed ID: 30558790
[TBL] [Abstract][Full Text] [Related]
11. miR-871-5p/PGC1α Regulates Aging-Induced Lipid Deposition in Hepatocytes Through Fatty Acid β-Oxidation.
Zheng Y; Chen X; Lu T; Lin Z; Liu C; Yuan D; Yuan C
J Gerontol A Biol Sci Med Sci; 2023 Oct; 78(11):2007-2015. PubMed ID: 37539727
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-376b-3p ameliorates nonalcoholic fatty liver disease by targeting FGFR1 and regulating lipid oxidation in hepatocytes.
Wang XY; Lu LJ; Li YM; Xu CF
Life Sci; 2022 Nov; 308():120925. PubMed ID: 36057399
[TBL] [Abstract][Full Text] [Related]
13. A negative feedback loop between microRNA-378 and Nrf1 promotes the development of hepatosteatosis in mice treated with a high fat diet.
Zhang T; Zhao X; Steer CJ; Yan G; Song G
Metabolism; 2018 Aug; 85():183-191. PubMed ID: 29625129
[TBL] [Abstract][Full Text] [Related]
14. Uric acid induced hepatocytes lipid accumulation through regulation of miR-149-5p/FGF21 axis.
Chen S; Chen D; Yang H; Wang X; Wang J; Xu C
BMC Gastroenterol; 2020 Feb; 20(1):39. PubMed ID: 32070295
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA Mirt2 upregulates USP10 expression to suppress hepatic steatosis by sponging miR-34a-5p.
Zhang B; Li H; Li D; Sun H; Li M; Hu H
Gene; 2019 Jun; 700():139-148. PubMed ID: 30898698
[TBL] [Abstract][Full Text] [Related]
16. miR-125a-5p ameliorates hepatic glycolipid metabolism disorder in type 2 diabetes mellitus through targeting of STAT3.
Xu L; Li Y; Yin L; Qi Y; Sun H; Sun P; Xu M; Tang Z; Peng J
Theranostics; 2018; 8(20):5593-5609. PubMed ID: 30555566
[TBL] [Abstract][Full Text] [Related]
17. CircLDLR acts as a sponge for miR-667-5p to regulate SIRT1 expression in non-alcoholic fatty liver disease.
Yuan X; Li Y; Wen S; Xu C; Wang C; He Y; Zhou L
Lipids Health Dis; 2022 Nov; 21(1):127. PubMed ID: 36443854
[TBL] [Abstract][Full Text] [Related]
18. BTG1 ameliorates liver steatosis by decreasing stearoyl-CoA desaturase 1 (SCD1) abundance and altering hepatic lipid metabolism.
Xiao F; Deng J; Guo Y; Niu Y; Yuan F; Yu J; Chen S; Guo F
Sci Signal; 2016 May; 9(428):ra50. PubMed ID: 27188441
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-126b-5p Exacerbates Development of Adipose Tissue and Diet-Induced Obesity.
Shen L; He J; Zhao Y; Niu L; Chen L; Tang G; Jiang Y; Hao X; Bai L; Li X; Zhang S; Zhu L
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638602
[TBL] [Abstract][Full Text] [Related]
20. A novel role of CRTC2 in promoting nonalcoholic fatty liver disease.
Han HS; Kim SG; Kim YS; Jang SH; Kwon Y; Choi D; Huh T; Moon E; Ahn E; Seong JK; Kweon HS; Hwang GS; Lee DH; Cho KW; Koo SH
Mol Metab; 2022 Jan; 55():101402. PubMed ID: 34838715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
